Japan Medical Dynamic Marketing, INC. (JMDMF)
OTCMKTS · Delayed Price · Currency is USD
3.340
-1.850 (-35.65%)
At close: Apr 1, 2025
Orchard Therapeutics Revenue
Japan Medical Dynamic Marketing, INC. had revenue of 5.92B JPY in the quarter ending June 30, 2025, a decrease of -2.19%. This brings the company's revenue in the last twelve months to 24.98B, up 4.84% year-over-year. In the fiscal year ending March 31, 2025, Japan Medical Dynamic Marketing, INC. had annual revenue of 25.11B with 8.36% growth.
Revenue (ttm)
24.98B JPY
Revenue Growth
+4.84%
P/S Ratio
0.55
Revenue / Employee
46.43M JPY
Employees
538
Market Cap
94.93M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 25.11B | 1.94B | 8.36% |
Mar 31, 2024 | 23.18B | 1.87B | 8.78% |
Mar 31, 2023 | 21.31B | 2.11B | 11.01% |
Mar 31, 2022 | 19.19B | 2.46B | 14.67% |
Mar 31, 2021 | 16.74B | -1.35B | -7.44% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |